The largest outbreak of Ebola occurred in West Africa
In 2014, the World Health Organization (WHO) reported that largest outbreak of Ebola in history had occurred, and…
Biotechnology | CDC | Infectious Disease | Influenza | Life Science News | Non-Profit Research | Therapeutics | Vaccine
The CDC initiated the Global Heath Security Agenda
On Aug. 1, 2014, the U.S. Centers for Disease Control and Prevention (CDC) initiated the Global Heath Security…
Diagnostics | Infectious Disease | Life Science History | Life Science News | Non-Profit Research | Therapeutics | Vaccine | WHO
A 2-year-old boy in the Guinean village of Meliandou fell ill with Ebola
On Dec. 26, 2013, a 2-year-old boy in the remote Guinean village of Meliandou fell ill with a…
CDC published guidance for HBV protection and postexposure management of healthcare personnel
On Dec. 20, 2013, the U.S. Centers for Disease Control and Prevention (CDC) published guidance for HBV protection…
Merck recalled one batch of Gardasil, a human papillomavirus vaccine
On Dec. 16, 2013, the Centers for Disease Control and Prevention (CDC) was informed by Merck that the…
Project Tycho published in the New England Journal of Medicine
On Nov. 28, 2013 “Project Tycho,” was a mammoth study that tracked nearly 88 million cases of disease…
CDC published new recommendations for use of Japaneseï¾ encephalitis vaccine in children
On Nov. 15, 2013, the Advisory Committee on Immunization Practices (ACIP) voted to extend existing recommendations for use…
FDA expanded age indication for Menveo to include infants and toddlers age 2 through 23 months
On Aug. 1, 2013, Novartis announced the U.S. Food and Drug Administration (FDA) had approved Menveo (Meningococcal [Groups…
CDC partnered with Public Health laboratories to define optimal size for influenza virologic surveillance
On Jul. 2, 2013, the U.S. Centers for Disease Control and Prevention (CDC) partnered with Association of Public…
CDC issued recommendations for PCV and PPSV vaccination of children with immunocompromising conditions
On Jun. 28, 2013, the Advisory Committee on Immunization Practices (ACIP) recommended routine use of 13-valent pneumococcal conjugate…
ACIP voted to recommend FluBlok influenza vaccine for people age 18 through 49ï¾ with egg allergy
On Jun. 20, 2013, the Advisory Committee on Immunization Practices (ACIP) voted 13 to 0, in favor of…
Biotechnology | CDC | Life Science News | Measles | Vaccine
CDC published Summary recommendations for preventing measles, rubella, congenital rubella syndrome, and mumps
On Jun. 14, 2013, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices…
FDA approved Fluzone as the third quadrivalent influenza vaccine licensed for US use
On Jun. 10, 2013, Sanofi Pasteur announced the U.S. Food and Drug Administration (FDA) had approved the supplemental…
Booster dose of yellow fever vaccine not needed, according to WHO
On May 7, 2013, the World Health Organization (WHO) announced that the yellow fever ‘booster’ vaccination given ten…
Global Leaders launched Six-Year Plan to Deliver a Polio-Free World by 2018
On Apr. 25, 2013, the Global Polio Eradication Initiative (GPEI) announced a comprehensive six-year plan, the first plan…
Texas A&M System and GlaxoSmithKline receive U.S. Government approval to establish influenza vaccine facility In Texas
On Mar. 26, 2013, GlaxoSmithKline and the Texas A&M University System announced that the U.S. Department of Health…
Biotechnology | CDC | Life Science News | Non-Profit Research | Therapeutics | Vaccine | Women's Health
ACIP recommended a dose of Tdap vaccine during each pregnancy
On Feb. 22, 2013, the Advisory Committee on Immunization Practices (ACIP) recommended that unvaccinated pregnant women receive a…
FDA approved quadrivalent formulation of Fluarix
On Dec. 14, 2012, the U.S. Food and Drug Administration (FDA) announced it had approved GlaxoSmithKline’s quadrivalent formulation…
FDA approved first seasonal influenza vaccine manufactured using cell culture technology
On Nov. 20, 2012, the U.S. Food and Drug Administration (FDA) announced it had approved first seasonal influenza…
ACIP voted to recommend use of HibMenCY vaccine in infants at increased risk for meningococcal disease
On Oct. 24, 2012, the Immunization Practices Advisory Committee (ACIP) voted to recommend use of HibMenCY (Menhibrix, GlaxoSmithKline),…
ACIP voted to recommend that pregnant women receive a dose of Tdap during each pregnancy
On Oct. 24, 2012, the Immunization Practices Advisory Committee (ACIP) voted 14-0 with one abstention to recommend that…
LigoCyte Pharmaceuticals was acquired Takeda Pharmaceutical
On Oct. 3, 2012, Takeda Pharmaceutical acquired LigoCyte for an upfront payment of $60 million, with future contingent…
The Serum Institute of India acquired Bilthoven Biologicals from The Netherlands Government
On Jul. 4, 2012, the Serum Institute of India made its first International acquisition by acquiring Bilthoven Biologicals,…
Biotechnology | Disease | FDA | Life Science News | Vaccine
FDA approved HibMenCY vaccine for infants
On Jun. 24, 2012, the U.S. Food and Drug Administration (FDA) announced it had approved HibMenCY (Menhibrix, GlaxoSmithKline),…
The European Region of the world was certified as polio-free
On Jun. 21, 2012, the European Region of the world was certified as polio-free. Certification followed years of…
U.S. Dept of HHS Inspector General released report titled “Vaccines for Children Program: Vulnerabilities in Vaccine Management”
On Jun. 5, 2012, the U.S. Department of Health and Human Services (HHS) Office of the Inspector General…
Washington State Secretary of Health declared a pertussis epidemic
On Apr. 3, 2012, the Washington State Secretary of Health declared a pertussis epidemic. By Jun. 16, the…
Biotechnology | Diagnostics | Influenza | Life Science News | Non-Profit Research | Therapeutics | Vaccine
Mice bred to more closely resemble a genetic variation in humans help target an annual outbreak: the flu
On Feb. 21, 2012, as part of a national collaboration, Oregon Health & Science University researchers were studying…
Vaccines containing cell-cultured virus became available
In 2012, vaccines containing cell-cultured virus became available. Even though eggs continued to be the primary means of…
FDA expanded use of Prevnar 13 vaccine to include people ages 50 and older
On Dec. 30, 2011, Pfizer announced that the U.S. Food and Drug Administration (FDA) had granted approval of…